Sponsor a Webinar or Podcast Episode
In this episode, Scott Becker examines GoodRx’s 30% surge after entering the weight loss drug market, the rapid growth of hims and hers, and Novo Nordisk’s move to cut prices on Ozempic as competition in the GLP-1 space intensifies.
Podcast: Play in new window | Download
Discussions about private equity and business with Scott Becker.
Subscribe and get the Becker Private Equity & Business Newsletter sent straight to your inbox.
Take your brand to new heights by sponsoring an episode of the Becker Private Equity & Business Podcast! Engage with a powerful audience of decision-makers, investors, and industry leaders eager for insights into business and finance.
Our listeners are tuned in for expert advice and actionable strategies—place your message at the center of the conversation with a platform they trust.
Join us to amplify your brand’s reach and connect with an engaged, high-value audience.